The Journal of Toxicological Sciences, published by the Japanese Society of Toxicological Sciences, is a prominent academic journal dedicated to the comprehensive study of toxicology and its related fields. Since its inception in 1976, the journal has provided a vital platform for researchers and professionals to disseminate innovative findings and insights in toxicology, with a focus on both experimental and clinical studies. Positioned in the Q3 quartile across various relevant categories, including Medicine (miscellaneous) and Toxicology as of 2023, the journal plays an essential role in advancing our understanding of toxic substances and their effects on biological systems. Although currently not open access, the journal maintains high academic standards and is indexed in Scopus, ranking #96 in Toxicology. Offering unique perspectives from Japan, it encourages global collaboration and discourse among toxicologists, making it an invaluable resource for students, researchers, and industry professionals alike.

TOXICOLOGY LETTERS is a prominent journal dedicated to advancing the field of toxicology, providing a platform for high-quality research and reviews that explore the effects of chemical substances on biological systems. Published by Elsevier Ireland Ltd, this peer-reviewed journal has established itself as a vital resource in toxicological research since its inception in 1977, with a convergence of studies extending to 2024. With an impressive Scopus ranking, positioned at #28 out of 133 in the Toxicology category, TOXICOLOGY LETTERS garners a respectable percentile of 79, highlighting its significance in the academic community. Although it is not an open-access journal, its research is accessible through institutional subscriptions, ensuring that critical insights into human health and environmental safety are disseminated effectively. Being categorized in the Q2 quartile in both Medicine (miscellaneous) and Toxicology for 2023 further emphasizes its relevance and impact in these fields. This journal aims to foster collaboration between researchers and professionals, encouraging the exploration of innovative solutions to chemical hazards and the promotion of safer practices in pharmacology and toxicology.

Inhalation Toxicology, published by Taylor & Francis Ltd, is a premier journal dedicated to advancing the field of toxicology with a particular focus on inhalation exposure and its impact on human health. Established in 1989, this journal provides a vital platform for original research, reviews, and case studies that explore the toxicological effects of inhaled substances, making it essential reading for researchers, health professionals, and regulatory scientists. With an Impact Factor that situates it in the Q3 category in both Health, Toxicology and Mutagenesis, the journal asserts its relevance within the scientific community, particularly emphasizing its contributions as indexed by Scopus rankings in related fields. Although it follows a traditional access model, the journal's commitment to delivering high-quality research continues to foster significant discussions and advancements in understanding inhalation toxicology. For those at the forefront of environmental science and pharmacology, Inhalation Toxicology is an indispensable resource for both current research and future innovations in the discipline.

Current Research in Toxicology is a pioneering journal published by ELSEVIER that serves as a vital platform for disseminating cutting-edge research in the field of toxicology, spanning from biological impacts to pharmacological applications. With an ISSN of 2666-027X and an impressive Q2 ranking in key categories such as Applied Microbiology and Biotechnology, Health, Toxicology and Mutagenesis, and Toxicology, this journal underscores its commitment to high-quality research and significant contributions to the scientific community. Based in the Netherlands, Current Research in Toxicology aims to bridge the gap between academia and industry by providing rigorously peer-reviewed articles that cover a wide array of topics including novel methodologies, regulatory challenges, and emerging trends within the domain. The journal is accessible through various platforms, making it essential for researchers, professionals, and students eager to stay updated on the latest findings and advancements in toxicology. With a comprehensive focus on integrating theory with practical application, this journal is poised to influence future studies and policies in health and environmental science.

TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY is a pivotal journal published by Taylor & Francis Ltd, addressing critical intersections between environmental chemistry and toxicology since its inception in 1979. With its ISSN 0277-2248 and E-ISSN 1029-0486, the journal serves as a platform for rigorous research and innovative methodologies in pollution control, health implications of environmental chemicals, and the broader spectrum of toxicological studies. Although it currently does not offer open access, the journal's impact in the field is underscored by its Category Quartiles rankings in 2023, placing it in Q3 across Environmental Chemistry, Health, Toxicology and Mutagenesis, and Pollution categories. Furthermore, its Scopus rankings reveal its significant role within the scientific community, specifically in areas such as Environmental Science and Toxicology. The journal aspires to foster multidisciplinary dialogue and advance knowledge that contributes to environmental sustainability and public health, making it an essential resource for researchers, professionals, and students dedicated to these fields.

Environmental Toxicology and Pharmacology, published by Elsevier, is a leading journal dedicated to advancing our understanding of the effects of environmental pollutants on biological systems. With an ISSN of 1382-6689 and an E-ISSN of 1872-7077, this journal covers a wide range of studies related to toxicology, pharmacology, and environmental health. The journal is classified as Q2 in key categories such as Health, Toxicology and Mutagenesis and Medicine (miscellaneous), and sits impressively in Q1 for Toxicology, reflecting its strong impact in the field. As of 2023, it ranks #30 out of 133 in Toxicology and #40 out of 148 in Health, indicating its high relevance and contribution to research. While the journal is not currently open access, it remains a pivotal resource for researchers, professionals, and students seeking to explore the intricacies of environmental health effects. Its commitment to publishing high-quality peer-reviewed research positions it as a crucial platform for scientific dialogue and discovery.

TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

Chemical Research in Toxicology is a premier journal published by the American Chemical Society, dedicated to advancing the understanding of toxicological effects associated with chemical substances. Since its inception in 1988, this esteemed journal has maintained a robust impact factor, ranking in the Q1 quartile for both Medicine (miscellaneous) and Toxicology as of 2023, reflecting its significance and influence in the fields of pharmacology and toxicology. With an impressive Scopus ranking at #16 out of 133 in the Toxicology category, it serves as a vital resource for researchers, professionals, and students seeking cutting-edge insights and scholarly articles that bridge the gap between chemistry and toxicological science. Although not an open-access publication, it continues to provide comprehensive analyses and original research that inform safe chemical practices and regulatory policies, further enhancing its role in public health and safety.

TOXICOLOGY IN VITRO is a premier journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest advancements in the field of toxicology, particularly through in vitro methodologies. With an ISSN of 0887-2333 and an E-ISSN of 1879-3177, this journal serves as a critical platform for researchers aiming to disseminate their findings in toxicology, emphasizing innovative approaches and applications in pharmacology and toxicology. Featuring a commendable impact factor and classified in the second quartile (Q2) for both Medicine (miscellaneous) and Toxicology in 2023, the journal holds a significant position within the academic community, ranking 41st out of 133 in the Toxicology category according to Scopus, representing the 69th percentile. Despite being a subscription-based publication, it continuously attracts submissions from leading scientists worldwide, fostering a vibrant exchange of scientific knowledge. Since its inception in 1987, TOXICOLOGY IN VITRO has consistently aimed to enhance understanding of toxicological challenges, making it an invaluable resource for professionals, students, and researchers dedicated to developing safer pharmaceuticals and understanding the biological pathways influenced by potential toxic agents.

JOURNAL OF APPLIED TOXICOLOGY, published by Wiley, stands as a leading platform in the field of toxicology, focusing on the rigorous examination of chemical substances and their effects on biological systems. With an impressive Impact Factor, it ranks in the top quartile (Q2) for toxicology journals, reflecting its esteemed position within the scientific community. The journal, identifiable by its ISSN 0260-437X and E-ISSN 1099-1263, has been an invaluable resource since its inception in 1981, and it continues to serve as a conduit for innovative research and practical applications through 2024. Positioned at the forefront of the field, it garners recognition in the Scopus Rankings, where it ranks #31 out of 133 journals in the toxicology category, placing it in the 77th percentile—a testament to its contribution to the advancement of pharmacology and toxicological sciences. While not an open-access journal, it remains accessible to a wide audience of researchers, professionals, and students eager to explore cutting-edge findings in applied toxicology, making it a pivotal resource for enhancing knowledge and fostering collaboration in the field.